𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Combined androgen blockade for advanced prostatic carcinoma

✍ Scribed by Goktas, S; Ziada, A; Crawford, E D


Book ID
110073131
Publisher
Nature Publishing Group
Year
1999
Tongue
English
Weight
339 KB
Volume
2
Category
Article
ISSN
1365-7852

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Systematic review and meta-analysis of m
✍ David J. Samson; Jerome Seidenfeld; Brian Schmitt; Vic Hasselblad; Peter C. Albe πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 131 KB πŸ‘ 1 views

## Abstract ## BACKGROUND The current systematic review and meta‐analysis compared monotherapy and combined androgen blockade in the treatment of men with advanced prostate carcinoma. Outcomes of interest included overall, cancer specific, and progression‐free survival; time to treatment failure;

Twenty years of controversy surrounding
✍ Judd W. Moul πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 71 KB

The current issue of __Cancer__ includes a report on a concise, randomized controlled trial (RCT) with long‐term follow‐up that favors combined androgen blockade with bicalutamide versus lutenizing hormone‐releasing hormone monotherapy in Japanese men with locally advanced and metastatic prostate ca

Monotherapy versus combined androgen blo
✍ Abelardo Errejon; E. David Crawford πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 33 KB

Despite a number of large randomized clinical trials, there still is uncertainty regarding the value of maximal androgen blockade in the treatment of patients with advanced prostate carcinoma. In the referenced article, the authors provide a very comprehensive review of the literature concerning one